Theravance Biopharma is teaming up with Janssen Biotech to develop a group of drugs for intestinal diseases such as ulcerative colitis and Crohns. Dublin Ireland basedTheravance Biopharma NASDAQ TBPH which has U.S. operations in South San Francisco CA will...
↧